State bills: Missouri · Business & Consumers
What's moving in state legislatures -- introductions, committee action, floor votes and sponsors.
Filter bills
-
SB 1056 — Missouri
Modifies provisions relating to the sale of motor vehicles and vessels
SB 1056 - This act establishes the "Missouri Voter Vehicle Board" within the Department of Commerce and Insurance, which shall be responsible for the licensing of all manufacturers, motor vehicle dealers, boat dealers, wholesale motor vehicle auctions, public motor vehicle auctions, and wholesale motor vehicle dealers, as such terms are defined in the act. All responsibilities of the Department of Revenue in effect before August 28, 2026, shall be transferred to the Board. The Board shall be composed of nine members selected by the Governor with the advice and consent of the Senate. Five of such members shall be licensed franchised new motor vehicle dealers, two shall be licensed used motor vehicle dealers, one shall be a licensed powersport dealer, and one shall be a public member, and such members shall serve four year terms. (Section 301.1003) The act authorizes the Board to employ an executive director, who shall serve at the pleasure of the Board and who shall have the duties as described in the act. (Section 301.1006) The act establishes the "Missouri Motor Vehicle Board Fund", which shall consist of all fees charged by the Board other than fees for the issuance of license plates and certificates of number, and such moneys shall be utilized to implement the provisions of the act. (Section 301.1009) The Board shall be empowered to establish the qualifications of applicants for licensure, to receive complaints concerning the conduct of persons and businesses licensed by the Board and concerning sales of motor vehicles by persons not licensed by the Board, as well as other powers and duties as described in the act. (Section 301.1012) The act provides that it shall be unlawful to sell or display with an intent to sell six or more motor vehicles in a calendar year unless such person is licensed as described in the act. A violation of this provision shall be a class A misdemeanor, and a second or subsequent conviction shall be a class E felony. (Section 301.1015) Licenses issued by the Board under the act shall be for a period of twelve consecutive months unless adjusted by the Board. Each application shall be accompanied by proof that the applicant has completed an educational seminar relating to the dealer requirements of the act. A dealer licensed under the act shall not terminate its business without providing the Board with a minimum of thirty days' notice. (Section 301.1018) The act requires that every application for a license shall include a certification that the applicant has an established place of business, with such certification to be performed by a uniformed member of the Highway Patrol. Locations that qualify as an established place of businesses are described in the act. The act requires all applicants to furnish with the application a corporate surety bond or an irrevocable letter of credit issued by any state or federal financial institution in the sum of fifty thousand dollars, as described in the act. Fees for licensure shall not be less than $150 for initial licensure and license renewal, and shall generate sufficient revenues to implement the act. (Section 301.1021) Upon licensure, the Board shall assign a distinctive dealer license number or certificate of number to the applicant and issue one number plate and two additional number plates as quickly as practicable after presentment of the application and payment by the applicant of a $50 fee for the first plate, and $10.50 fee for each additional plate, as described in the act. (Section 301.1024) A person licensed under the act shall permit an employee of the Board or any law enforcement official, as defined in the act, to inspect the person's business documents, as described in the act. (Section 301.1027) The Board may refuse to issue any license to and cause a complaint to be filed against any license holder for causes specified in the act. (Section 301.1030) Upon a finding by the Administrative Hearing Commission, any person violating the provisions of the act may be assessed a civil penalty by the Board in lieu of any other penalty authorized by the act, provided that such civil penalty shall not exceed $500 per violation or $5,000 in the aggregate, and shall be deposited to the credit of the State Highway Fund. (Section 301.1033) The Board may issue process, subpoena witnesses, administer oaths, examine books and papers, and cause the deposition of witnesses to be taken. Any person failing to obey a subpoena or to appear at any hearing or proceeding without reasonable cause shall be guilty of a class B misdemeanor. (Section 301.1036) The act provides advertising standards that shall be followed by any person licensed by the act. (Section 301.1042) It shall be unlawful for a motor vehicle dealer to sell or offer to sell any motor vehicle away from the dealer's registered place of business, except as provided in the act. The Department of Commerce and Insurance may assess a fine of up to $1,000 for a violation of this provision. (Section 301.1045) An out-of-state show promoter of recreational vehicles may hold recreational vehicle shows or exhibits with recreational vehicles in this state if the show or exhibition has a minimum of ten recreational vehicle dealers licensed in this state and more than fifty percent of the participating recreational vehicle dealers are licensed in this state. (Section 301.1054) Finally, the act repeals several provisions of current law relating to the sale of motor vehicles and vessels. TAYLOR MIDDLETON
-
SB 957 — Missouri
Establishes the Missouri Statewide Mechanical Contractors Licensing Act
SB 957 - This act establishes the Missouri Statewide Mechanical Contractor Licensing Act. Under this act, the Division of Professional Registration ("Division") shall regulate the statewide mechanical contractor license, the statewide mechanical journeyman license, and the statewide mechanical apprentice license for mechanical work. The provisions of this act shall not apply to mechanical work performed in Greene, Newton, and Jasper counties. This act establishes the Missouri Mechanical Contractor Licensing Fund in the state treasury, which shall be expended for the administration of this act. A statewide license shall not be required to perform mechanical work in a political subdivision, but shall be accepted in lieu of an equivalent local license if a political subdivision requires a local license for mechanical work. Any person operating as a mechanical contractor in a political subdivision that does not require a local license shall not be required to possess a statewide license to operate as a mechanical contractor in such political subdivision. If a political subdivision does not recognize a statewide license in lieu of a local license, a statewide mechanical contractor license holder may file a complaint with the Division, which may investigate such complaint. If the Division finds that the political subdivision failed to recognize a statewide mechanical contractor license, the Division shall notify the political subdivision of such violation and grant the political subdivision thirty days to comply. If after thirty days the political subdivision does not comply, the Division shall notify the Director of the Department of Revenue, who shall withhold any moneys the political subdivision would otherwise be entitled to from local sales tax until the political subdivision is in compliance. Applicants for the statewide licenses shall meet certain training, education, and experience criteria set forth in the act equal to those of the mechanical code of St. Louis County as of April 18, 2023. A corporation, firm, institution, organization, or company seeking to engage in mechanical work shall have at least one statewide mechanical contractor licensee in its employ if the political subdivision requires a license. For the purposes of performing residential work, a statewide mechanical contractor or statewide mechanical journeyman, or the equivalent local licensee, shall perform, direct, inspect, or supervise the work. For all other mechanical work, at least one statewide mechanical journeyman shall be on site for every statewide mechanical apprentice performing the work, or the equivalent local licensee. The Division may refuse to issue any license and may cause a complaint to be filed with the Administrative Hearing Commission against any holder of a license for causes set forth in the act. Upon a finding by the Administrative Hearing Commission that grounds for disciplinary action are met, the Division may censure or place such a person on probation for a period not to exceed five years, or may suspend, for a period not to exceed three years, or revoke any license. Upon a judicial or administrative finding of a violation of this act, the Division may assess fines up to $5,000. Any person who knowingly violates the provisions of this act is guilty of a class B misdemeanor. This act is substantially similar to SB 31 (2025), SB 392 (2025), SB 1116 (2024), SB 1498 (2024), and SS/SB 80 (2023) and is similar to HB 2659 (2026), SB 523 (2025), HB 547 (2025), SB 1487 (2024), HB 2207 (2024), HB 1083 (2023), SCS/SB 867 (2022), HB 2050 (2022), SS/SB 11 (2021), HB 500 (2021), SCS/SB 559 (2020), provisions in HCS/SS/SCS/SBs 673 & 560 (2020), HCS/HB 1891 (2020), HCS/HB 326 (2019), SB 376 (2019), in SCS/HB 705 (2019), and HB 2673 (2018). KATIE O'BRIEN
-
SB 840 — Missouri
Creates provisions relating to cost-sharing under health benefit plans
SB 840 - This act provides that when calculating an enrollee's overall contribution to an out-of-pocket max or any cost-sharing requirement under a health benefit plan, a health carrier or pharmacy benefits manager shall include any amounts paid by the enrollee or paid on behalf of the enrollee for any medication for which a generic substitute is not available. Additionally, no health carrier or pharmacy benefits manager shall design benefits in a manner that takes into account the availability of any cost-sharing assistance program for any medication for which a generic drug substitute is not available. The provisions of this act shall apply to health benefit plans entered into, amended, extended, or renewed on or after August 28, 2026. This act is identical to SB 1448 (2026), SB 1327 (2026), HB 2279 (2026), HB 1941 (2026), HB 1681 (2026), HB 79 (2025) and substantially similar to provisions in HCS/HB 1941, 2279, & 1681 (2026), SB 45 (2025), and similar to provisions in SB 187 (2025), SB 512 (2025), SB 1106 (2024), SB 844 (2024), SB 1190 (2024), HCS/HB 442 (2023), HB 1628 (2024), SB 269 (2023), and SB 1031 (2022). TAYLOR MIDDLETON
-
SB 900 — Missouri
Modifies provisions relating to assisted reproductive technology
SB 900 - This act modifies provisions relating to assisted reproductive technology. DEFINITION OF UNBORN CHILD (Section 1.205) This act modifies the definition of "unborn child" or "unborn children" to exclude human embryos created through assisted reproductive technology, including in vitro fertilization, prior to successful implantation in the uterus. These provisions are identical to SB 605 (2025) and HB 3244 (2026), and substantially similar to SB 1486 (2024), and similar to HB 2845 (2024). DIAGNOSIS AND TREATMENT OF INFERTILITY (Section 376.1211) This act requires certain health benefit plans providing pregnancy-related benefits to include coverage for the diagnosis and treatment of infertility, as described in the act. These provisions contain an exception for health benefit plans issued by or to religious institutions or organizations. These provisions are identical to HB 2724 (2026) and HB 3244 (2026), and substantially similar to HB 487 (2025). TAYLOR MIDDLETON
-
SB 929 — Missouri
Enacts provisions relating to insurance coverage of self-administered hormonal contraceptives
SB 929 - Under this act, current law requiring certain health benefit plans to provide coverage for contraceptives lasting up to 90 days, or 180 days for generic self-administered hormonal contraceptives, shall no longer be in effect after December 31, 2026. Instead, certain health benefit plans issued or renewed on or after January 1, 2027, shall be required to cover a supply of self-administered hormonal contraceptives, including brand-name and generic contraceptives, intended to last up to one year. This act is substantially similar to provisions in the truly agreed to and finally passed SS/SCS/HCS/HB 2372 (2026), the truly agreed to and finally passed CCS/SS/HCS/HB 2596 (2026), and HB 2370 (2026), and similar to a provision in SCS/SB 178 (2025), HCS/SS/SB 7 (2025), HCS/SB 94 (2025), the perfected HCS/HB 2413 (2024), SB 821 (2024), and SB 1321 (2024). TAYLOR MIDDLETON
-
SB 852 — Missouri
Prohibits the use of credit scores in determining automobile insurance rates
SB 852 - This act provides that, for all automobile insurance contracts entered into on or after August 28, 2026, no insurer shall utilize any information obtained directly or indirectly from a consumer reporting agency or any insurance credit score that relies on information obtained directly or indirectly from a consumer reporting agency for the purpose of determining the rate charged for such contract. This act is identical to HB 2632 (2026). TAYLOR MIDDLETON
-
SB 921 — Missouri
Creates new provisions relating to digital forms of identification
SB 921 - This act prohibits public entities from requiring any person to obtain or maintain any digital form of identification, as that term is defined in the act. The use of a digital form of identification may be offered by a public entity as an option when interacting with any person, but the person cannot be required to obtain or use a digital form of identification unless a physical form of identification is offered as an alternative in lieu of the digital form of identification. The use of a digital form of identification may also be offered by a private entity as an option when interacting with any person. A person who has agreed to use a digital form of identification shall be permitted, upon request, to view, correct, destroy, or restrict the usage of all personal data associated with the person's own identification. A person who has authorized the usage of any personal data associated with the person's digital form of identification for one purpose shall not be deemed authorization for any other purpose. Personal data of any person may only be collected for the purpose stated by the public or private entity and only upon the consent of each individual person, or in the case of a minor, only upon consent of a parent of the minor. Personal data of any person shall not be sold or transferred to any public or private entity without the consent of the person. A public entity shall not, with respect to any individual person, take any action or refuse to take any action based solely on the personal data of a person. Furthermore, a digital form of identification shall not be required by a public entity to enter any place of public accommodation. Any person may bring a cause of action in a court of competent jurisdiction if the person alleges that a public entity has violated this act. A public entity found by a court to have violated this act shall be liable to the person affected for not more than $150,000 per occurrence. This act shall not be construed to prohibit any public entity from complying with any lawful request from a law enforcement agency with respect to any person's personal data. The act additionally provides that no person shall be required to obtain a mobile driver's license. Furthermore, a person's driver's license shall not be linked with any automated license plate reader without the written consent of such person. TAYLOR MIDDLETON
-
SB 930 — Missouri
Creates provisions relating to anesthesia services
SB 930 - Under this act, no health carrier or health benefit plan shall establish, implement, or enforce any policy that imposes a time limit for the payment of anesthesia services provided during a medical or surgical procedure, as described in the act. This provision is identical to provisions in HCS/SB 94 (2025), HCS/HBs 1126 & 932 (2025), and SCS/HCS/HB 94 (2025), and similar to provisions contained in SCS/SB 841 (2026), HB 2570 (2026), the truly agreed to and finally passed SS/SCS/HCS/HB 2372 (2026), HCS/HBs 1945 & 2570, and HB 1944 (2026). TAYLOR MIDDLETON
-
SB 846 — Missouri
Enacts provisions relating to insurance coverage of health care services
SB 846 - This act enacts provisions relating to insurance coverage of pharmacy services. CLINICIAN-ADMINISTERED DRUGS (Section 376.411) This act provides that a health carrier or pharmacy benefits manager (PBM) shall not impose any penalty, impediment, differentiation, or limitation on participating providers for providing medically necessary clinician-administered drugs, regardless of whether the participating provider obtains the drugs from an in-network provider, including but not limited to refusing to approve or pay, or reimbursing less than the contracted payment amount. Carriers and PBMs shall not impose any penalty, impediment, differentiation, or limitation on a covered person who is administered medically necessary clinician-administered drugs, regardless of whether the participating provider obtains the drugs from an in-network provider, including but not limited to: limiting coverage or benefits; requiring an additional fee, higher co-payment, or higher coinsurance amount; or interfering with a patient's ability to obtain a clinician-administered drug from the patient's provider or pharmacy of choice by any means, including but not limited to inducing, steering, or offering financial or other incentives. Carriers and PBMs shall not impose any penalty, impediment, differentiation, or limitation on any pharmacy that is dispensing medically necessary clinician-administered drugs, regardless of whether the participating provider obtains the drugs from an in-network provider, including but not limited to requiring a pharmacy to dispense the drugs to a patient with the intention that the patient will transport the medication to a health care provider for administration. These provisions shall not apply if the clinician-administered drug is not otherwise covered by the carrier or PBM. These provisions are identical to provisions in SB 13 (2025), the introduced SB 751 (2024), HCS/HB 2267 (2024), SB 26 (2023), HCS/HB 198 (2023), SB 1129 (2022), and HB 2305 (2022), and similar to provisions in SB 921 (2022), SB 1129 (2022), and HB 2305 (2022). REFERENCE PRODUCTS AND BIOSIMILARS (Section 376.415) A health carrier or PBM providing coverage for a reference product or a biological product that is biosimilar to the reference product shall provide coverage for the reference product and all biological products that have been deemed biosimilar to the reference product. The scope, extent, and amount of the required coverage shall be the same, including but not limited to any payment limitations or cost-sharing obligations. These provisions are identical to provisions in SB 13 (2025), the introduced SB 751 (2024), HCS/HB 2267 (2024), SB 26 (2023), HCS/HB 198 (2023), SB 1129 (2022), and HB 2305 (2022), and similar to provisions in SB 921 (2022), SB 1129 (2022), and HB 2305 (2022). 340B DRUG PRICING PROGRAM (Section 376.416) Under this act, no health carrier or pharmacy benefits manager (PBM) shall discriminate against a covered entity or a pharmacy, as such terms are defined in the act, by: • Reimbursing a covered entity or pharmacy for a quantity of a 340B drug, as defined in the act, in an amount less than the carrier, PBM, or affiliate would pay to any other similarly situated pharmacy for such quantity of the drug on the basis that the entity or pharmacy is a covered entity or a pharmacy, or that the entity or pharmacy dispenses 340B drugs. (Section 376.416.2(1)); • Imposing any terms or conditions on covered entities or pharmacies which differ from the terms or conditions applicable to other similarly situated pharmacies or entities on the basis that the entity or pharmacy is a covered entity or dispenses 340B drugs, including but not limited to certain terms and conditions described in the act. (Section 376.416.2(2)); • Interfering with an individual's choice to receive a 340B drug from a covered entity or pharmacy. (Section 376.416.2(3)); • Discriminating in reimbursement to a covered entity or pharmacy based on the determination or indication a drug is a 340B drug. (Section 376.416.2(4)); • Requiring a covered entity or pharmacy to identify a 340B drug sooner than 45 days after the point of sale of the drug. (Section 376.416.2(5)); • Refusing to contract with a covered entity or pharmacy for reasons other than those that apply equally to entities or pharmacies that are not covered entities or similarly situated pharmacies, or on the basis that the entity or pharmacy is a covered entity as described under federal law, or on the basis that the entity or pharmacy is described as a covered entity under provisions of federal law. (Section 376.416.2(6)); • Denying the covered entity the ability to purchase drugs at 340B program pricing by substituting a rebate discount. (Section 376.416.2(7)); • Refusing to cover drugs purchased under the 340B drug pricing program. (Section 376.416.2(8)); or • Requiring a covered entity or pharmacy to reverse, resubmit, or clarify a 340B-drug pricing claim after the initial adjudication unless these actions are in the normal course of pharmacy business and not related to the 340B drug pricing, except as required by federal law. (Section 376.416.2(9)). The Director of the Department of Commerce and Insurance shall impose a civil penalty on any health carrier or PBM violating certain provisions of the act, not to exceed $5,000 per violation per day. (Section 376.416.3). These provisions are identical to provisions in SB 13 (2025), and similar to provisions in SB 372 (2025), HB 784 (2025), HB 785 (2025), HB 943 (2025), the introduced SB 751 (2024), SCS/SBs 978 & 1035 (2024), SB 1213 (2024), HCS/HB 2267 (2024), HB 1977 (2024), SB 26 (2023), HCS/HB 198 (2023), SB 426 (2023), HB 197 (2023), SB 921 (2022), HCS/HB 1677 (2022), SB 1129 (2022), and HB 2305 (2022). PRIOR AUTHORIZATION OF HEALTH CARE SERVICES (Sections 376.2100, 376.2102, 376.2104, 376.2106, and 376.2108) This act enacts provisions relating to prior authorization of health care services. Beginning January 1, 2027, health care providers shall not be required to obtain prior authorization for a health care service unless the health carrier or utilization review entity determines that in the most recent evaluation period, as defined in the act, less than 90% of the prior authorization requests submitted by that provider for that health care service were approved or would have been approved. Also beginning January 1, 2027, health care providers shall not be required to obtain prior authorization for any health care services unless the health carrier or utilization review entity has approved or would have approved less than 90% of all prior authorization requests submitted by that provider for health care services. Health carriers or utilization review entities may elect to have certain hospitals determine which of certain conditions, laid out in the act, the hospital will comply with in order to obtain a prior authorization exemption under the act. Exemptions from prior authorization under the act shall not apply to: pharmacy services, not to exceed the amount of $100,000; imaging services, not to exceed $100,000; cosmetic procedures that are not medically necessary; or investigative or experimental treatments. Maximum dollar amounts for these exceptions shall be adjusted annually for inflation as described in the act. The act further specifies certain prior authorization requests that shall not be included in making determinations under the act, specifies identification methods for the providers, includes provisions for the auditing and retraction of determinations under the act, allows for health carriers and utilization review entities to require providers to use an online portal to submit prior authorization requests, requires adverse determinations under the act to be reviewed by a clinical peer of the provider, and requires a grace period for patients who have received prior authorization for a 90-day supply of medication. Health carriers and utilization review entities shall notify providers within 25 days after a determination is made under the act, shall include in the notification certain information used in making the determination, shall establish an appeals process for the providers, and shall maintain an online prior authorization portal as described in the act. No health carrier or utilization review entity shall deny or reduce payment to a health care provider for a health care service for which the provider has prior authorization, except as described in the act. These provisions shall not apply to MO HealthNet services not provided through a managed care organization, or to providers who have not participated in a health benefit plan offered by the health carrier for at least one full evaluation period. These provisions are identical to provisions contained in SB 841 (2026), SB 13 (2025), HCS/SS#2/SB 79 (2025), HB 618 (2025), and similar to SB 897 (2026), HCS/HB 3010 (2026), HB 1675 (2026), SB 230 (2025), SB 751 (2024), SB 983 (2024), HB 1976 (2024), HB 2267 (2024), SB 576 (2023), and HB 1045 (2023). TAYLOR MIDDLETON
-
HR 3873 — Missouri
Informs the Governor that the 103rd General Assembly, Second Regular Session, is organized and ready for business
-
HR 3872 — Missouri
Informs the Senate that the House is duly convened and is in session ready for consideration of business